<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">porozendo</journal-id><journal-title-group><journal-title xml:lang="ru">Остеопороз и остеопатии</journal-title><trans-title-group xml:lang="en"><trans-title>Osteoporosis and Bone Diseases</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-2680</issn><issn pub-type="epub">2311-0716</issn><publisher><publisher-name>Endocrinology Research Centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/osteo13198</article-id><article-id custom-type="elpub" pub-id-type="custom">porozendo-13198</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL GUIDELINES</subject></subj-group></article-categories><title-group><article-title>Взаимосвязь между минеральной плотностью костной ткани, трабекулярным костным индексом и уровнем мочевой кислоты у женщин в постменопаузе с ревматоидным артритом</article-title><trans-title-group xml:lang="en"><trans-title>Relationship between bone mineral density, trabecular bone score and uric acid level in postmenopausal women with rheumatoid arthritis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0560-3495</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Козырева</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kozyreva</surname><given-names>M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Козырева Мария Витальевна - м.н.с. лаборатории остеопороза.</p><p>115522, Москва, Каширское ш., д. 34А</p><p>ResearcherID HHZ-3451-2022</p></bio><bio xml:lang="en"><p>Maria V. Kozyreva – MD.</p><p>34A, Kashirskoye sh., Moscow, 115522</p><p>ResearcherID HHZ-3451-2022</p></bio><email xlink:type="simple">doginya@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2809-0197</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Добровольская</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Dobrovolskaya</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Добровольская Ольга Валерьевна - к.м.н., н.с. лаборатории остеопороза.</p><p>115522, Москва, Каширское ш., д. 34А</p><p>ResearcherID AAF-2921-2021; Scopus Author ID 57197823569</p></bio><bio xml:lang="en"><p>Olga V. Dobrovolskaya - MD, PhD.</p><p>34A, Kashirskoye sh., Moscow, 115522</p><p>ResearcherID AAF-2921-2021; Scopus Author ID 57197823569</p></bio><email xlink:type="simple">olgavdobr@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6759-8367</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Никитинская</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Nikitinskaya</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Никитинская Оксана Анатольевна - к.м.н., начальник отдела координации научной деятельности, ученый секретарь ФГБНУ НИИР им. В.А. Насоновой.</p><p>115522, Москва, Каширское ш., д. 34А</p><p>ResearcherID AAF-2616-2021; Scopus Author ID 6504217119</p></bio><bio xml:lang="en"><p>Oksana A. Nikitinskaya - MD, PhD.</p><p>34A, Kashirskoye sh., Moscow, 115522</p><p>ResearcherID AAF-2616-2021; Scopus Author ID 6504217119</p></bio><email xlink:type="simple">nikitinskaya@niir.su</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4739-4302</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Торопцова</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Toroptsova</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Торопцова Наталья Владимировна - д.м.н., заведующий лабораторией остеопороза.</p><p>115522, Москва, Каширское ш., д. 34А</p><p>ResearcherID I-9030-2017; Scopus Author ID 6507457856</p></bio><bio xml:lang="en"><p>Natalia V. Toroptsova - MD, PhD.</p><p>34A, Kashirskoye sh., Moscow, 115522</p><p>ResearcherID I-9030-2017; Scopus Author ID 6507457856</p></bio><email xlink:type="simple">torop@irramn.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">ФГБНУ «Научно-исследовательский институт ревматологии имени В.А. Насоновой»<country>Россия</country></aff><aff xml:lang="en">V.A. Nasonova Research Institute of Rheumatology<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>31</day><month>08</month><year>2025</year></pub-date><volume>28</volume><issue>2</issue><fpage>4</fpage><lpage>10</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Козырева М.В., Добровольская О.В., Никитинская О.А., Торопцова Н.В., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Козырева М.В., Добровольская О.В., Никитинская О.А., Торопцова Н.В.</copyright-holder><copyright-holder xml:lang="en">Kozyreva M.V., Dobrovolskaya O.V., Nikitinskaya O.A., Toroptsova N.V.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.osteo-endojournals.ru/jour/article/view/13198">https://www.osteo-endojournals.ru/jour/article/view/13198</self-uri><abstract><sec><title>Обоснование</title><p>Обоснование. Мочевая кислота (МК) конечный продукт пуринового обмена у людей. МК рассматривается как антиоксидант, который предотвращает негативные эффекты окислительного стресса, связанного со старением и метаболическими заболеваниями. В некоторых исследованиях показаны как положительные, так и отрицательные ассоциации между МК и минеральной плотностью кости (МПК), а ее взаимосвязь с показателем трабекулярного костного индекса (ТКИ) не до конца изучена.</p></sec><sec><title>Цель</title><p>Цель. Определить взаимосвязь МПК и ТКИ с уровнем МК у женщин в постменопаузе с ревматоидным артритом (РА).</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. В одномоментное исследование включены 140 женщин (медиана возраста 65,0 [59,5; 70,0] лет) в постменопаузе с достоверным диагнозом РА. Проведено анкетирование по унифицированному опроснику, лабораторное обследование, выполнена двухэнергетическая рентгеновская абсорбциометрия поясничного отдела позвоночника (L1–L4) с определением трабекулярного костного индекса (ТКИ) и проксимального отдела бедра (ПОБ).</p></sec><sec><title>Результаты</title><p>Результаты. В обследованной группе деградированная микроархитектоника по ТКИ выявлена у 40,7% пациентов, а среднее значение МК составило 273,9±73,7 мкмоль/л. При корреляционном анализе уровня МК с МПК различных областей измерения и ТКИ выявлена положительная ассоциация между ним и МПК L1–L4 (r=0,025, p=0,003), МПК ПОБ в целом (r=0,23, p=0,007), МПК шейки бедра (ШБ) и негативная — с ТКИ (r=-0,18, p=0,035). В результате множественной линейной регрессии установлена значимая положительная ассоциация МПК L1–L4 и ПОБ в целом с МК и индексом массы тела (ИМТ), отрицательная — МПК ПОБ в целом и ТКИ с возрастом и уровня МК с ТКИ, в то время как МПК ШБ негативно связана с возрастом и позитивно — с ИМТ и приемом кальция, а с МК взаимосвязь не выявлена.</p></sec><sec><title>Заключение</title><p>Заключение. Наше исследование показало разнонаправленную взаимосвязь уровня МК с МПК и ТКИ у постменопаузальных женщин с РА: положительную — с МПК позвоночника и ПОБ в целом, негативную — с ТКИ.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Background</title><p>Background: uric acid (UA) is the end product of purine metabolism in humans. UA is considered as an antioxidant that prevents the negative effects of oxidative stress associated with aging and metabolic diseases. Some studies have shown both positive and negative associations between UA and bone mineral density (BMD) and its relationship with the trabecular bone score (TBS) is not fully understood.</p></sec><sec><title>Aim</title><p>Aim: to determine the relationship of BMD and TBS with UA level in postmenopausal women with rheumatoid arthritis (RA).</p></sec><sec><title>Materials and methods</title><p>Materials and methods: the cross-sectional study included 140 postmenopausal women (median age 65.0 [59.5; 70.0] years) with a reliable diagnosis of RA. A unified questionnaire survey was conducted, a laboratory examination and dual-energy X-ray absorptiometry of femur and lumbar spine (L1-L4) with determination of TBS were performed.</p></sec><sec><title>Results</title><p>Results: in the examined group, degraded microarchitecture was detected in 40.7% of patients, and the mean UA level was 273.9±73.7 mmol/L. Correlation analysis revealed a positive association between UA level and BMD of L1-L4 (r=0.025, p=0.003), total hip (TH) (r=0.23, p=0.007) and femoral neck (FN) (r=0,15, p=0,045) and a negative association with TBS (r=-0.18, p=0.035). Multiple linear regression revealed a significant positive association between BMD L1-L4 and TH with UA and body mass index (BMI), a negative association of BMD TH and TBS with age and UA level with TBS, while BMD FN was negatively associated with age and positively associated with BMI and calcium intake, but no relationship has been identified with UA.</p></sec><sec><title>Conclusion</title><p>Conclusion: our study showed an independent multidirectional relationship of UA level with BMD and TBS in postmenopausal women with RA: positive — with BMD L1-L4 and TH, negative — with TBS.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>мочевая кислота</kwd><kwd>минеральная плотность кости</kwd><kwd>трабекулярный костный индекс</kwd><kwd>остеопороз</kwd><kwd>ревматоидный артрит</kwd></kwd-group><kwd-group xml:lang="en"><kwd>uric acid</kwd><kwd>bone mineral density</kwd><kwd>trabecular bone score</kwd><kwd>osteoporosis</kwd><kwd>rheumatoid arthritis</kwd></kwd-group><funding-group xml:lang="ru"><funding-statement>Исследование выполнено в рамках поисковой научной темы ФГБНУ НИИР им. В.А. Насоновой «Прогностическая значимость нарушения пуринового обмена при ревматических заболеваниях» (регистрационный № 123041800013-3).</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Jin M, Yang F, Yang I et al. Uric acid, hyperuricemia and vascular diseases. Front Biosci. 2012;17:656–669. doi: https://doi.org/10.2741/3950</mixed-citation><mixed-citation xml:lang="en">Jin M, Yang F, Yang I et al. Uric acid, hyperuricemia and vascular diseases. Front Biosci. 2012;17:656–669. doi: https://doi.org/10.2741/3950</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Edwards NL. The role of hyperuricemia in vascular disorders [published correction appears in Curr Opin Rheumatol. 2010 Jan;22(1):107]. Curr Opin Rheumatol. 2009;21(2):132–137. doi: https://doi.org/10.1097/BOR.0b013e3283257b964</mixed-citation><mixed-citation xml:lang="en">Edwards NL. The role of hyperuricemia in vascular disorders [published correction appears in Curr Opin Rheumatol. 2010 Jan;22(1):107]. Curr Opin Rheumatol. 2009;21(2):132–137. doi: https://doi.org/10.1097/BOR.0b013e3283257b964</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Glantzounis GK, Tsimoyiannis EC, Kappas AM, Galaris DA. Uric acid and oxidative stress. Curr. Pharm. Des. 2005;11(32):4145–4151. doi: https://doi.org/10.2174/138161205774913255</mixed-citation><mixed-citation xml:lang="en">Glantzounis GK, Tsimoyiannis EC, Kappas AM, Galaris DA. Uric acid and oxidative stress. Curr. Pharm. Des. 2005;11(32):4145–4151. doi: https://doi.org/10.2174/138161205774913255</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Doehner W, Schoene N, Rauchhaus M, et al. Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies. Circulation. 2002;105:2619-2624. doi: https://doi.org/10.1161/01.CIR.0000017502.58595.ED</mixed-citation><mixed-citation xml:lang="en">Doehner W, Schoene N, Rauchhaus M, et al. Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies. Circulation. 2002;105:2619-2624. doi: https://doi.org/10.1161/01.CIR.0000017502.58595.ED</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Bowman GL, Shannon J, Frei B, et al. Uric acid as a CNS antioxidant. J Alzheimers Dis. 2010;19(4):1331–1336. doi: https://doi.org/10.3233/JAD-2010-1330</mixed-citation><mixed-citation xml:lang="en">Bowman GL, Shannon J, Frei B, et al. Uric acid as a CNS antioxidant. J Alzheimers Dis. 2010;19(4):1331–1336. doi: https://doi.org/10.3233/JAD-2010-1330</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Paganoni S, Zhang M, Quiroz Zarate A, et al. Uric acid levels predict survival in men with amyotrophic lateral sclerosis. J Neurol. 2012;259:1923–1928. doi: https://doi.org/10.1007/s00415-012-6440-7</mixed-citation><mixed-citation xml:lang="en">Paganoni S, Zhang M, Quiroz Zarate A, et al. Uric acid levels predict survival in men with amyotrophic lateral sclerosis. J Neurol. 2012;259:1923–1928. doi: https://doi.org/10.1007/s00415-012-6440-7</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Agidigbi TS, Kim C. Reactive oxygen species in osteoclast differentiation and possible pharmaceutical targets of ROS-mediated osteoclast diseases. Int. J. Mol. Sci. 2019;20(14):3576. doi: https://doi.org/10.3390/ijms20143576</mixed-citation><mixed-citation xml:lang="en">Agidigbi TS, Kim C. Reactive oxygen species in osteoclast differentiation and possible pharmaceutical targets of ROS-mediated osteoclast diseases. Int. J. Mol. Sci. 2019;20(14):3576. doi: https://doi.org/10.3390/ijms20143576</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Domazetovic V, Marcucci G, Iantomasi T, et al. Oxidative stress in bone remodeling: Role of antioxidants. Clin. Cases Miner. Bone Metab. 2017;14(2):209–216. doi: https://doi.org/10.11138/ccmbm/2017.14.1.209</mixed-citation><mixed-citation xml:lang="en">Domazetovic V, Marcucci G, Iantomasi T, et al. Oxidative stress in bone remodeling: Role of antioxidants. Clin. Cases Miner. Bone Metab. 2017;14(2):209–216. doi: https://doi.org/10.11138/ccmbm/2017.14.1.209</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Lean JM, Davies JT, Fuller K, et al. A crucial role for thiol antioxidants in estrogen-deficiency bone loss. J Clin Invest. 2003;112(6):915-923. doi: https://doi.org/10.1172/JCI18859</mixed-citation><mixed-citation xml:lang="en">Lean JM, Davies JT, Fuller K, et al. A crucial role for thiol antioxidants in estrogen-deficiency bone loss. J Clin Invest. 2003;112(6):915-923. doi: https://doi.org/10.1172/JCI18859</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Lean JM, Jagger CJ, Kirstein B, et al. Hydrogen peroxide is essential for estrogen-deficiency bone loss and osteoclast formation. Endocrinolo 2005;146:728–735. doi: https://doi.org/10.1210/en.2004-1021</mixed-citation><mixed-citation xml:lang="en">Lean JM, Jagger CJ, Kirstein B, et al. Hydrogen peroxide is essential for estrogen-deficiency bone loss and osteoclast formation. Endocrinolo 2005;146:728–735. doi: https://doi.org/10.1210/en.2004-1021</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Ahn SH, Lee SH, Kim B‐J, et al. Higher serum uric acid is associated with higher bone mass, lower bone turnover and lower prevalence of vertebral fracture in health postmenopausal women. Osteoporos Int. 2013;24:2961–70</mixed-citation><mixed-citation xml:lang="en">Ahn SH, Lee SH, Kim B‐J, et al. Higher serum uric acid is associated with higher bone mass, lower bone turnover and lower prevalence of vertebral fracture in health postmenopausal women. Osteoporos Int. 2013;24:2961–70</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Dalbeth N, Horne A, Mihov B, et al. Elevated urate levels do not alter bone turnover markers: Randomized controlled trial of inosine supplementation in postmenopausal women. Arthritis Rheumatol. 2021;73(9):1758–1764. doi: https://doi.org/10.1002/art.41691</mixed-citation><mixed-citation xml:lang="en">Dalbeth N, Horne A, Mihov B, et al. Elevated urate levels do not alter bone turnover markers: Randomized controlled trial of inosine supplementation in postmenopausal women. Arthritis Rheumatol. 2021;73(9):1758–1764. doi: https://doi.org/10.1002/art.41691</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Hu Z, Zhang L, Lin Z, et al. Prevalence and risk factors for bone loss in rheumatoid arthritis patients from South China: Modeled by three methods. BMC Musculoskelet. Disord. 2021;22(1):534. doi: https://doi.org/10.1186/s12891-021-04403-5</mixed-citation><mixed-citation xml:lang="en">Hu Z, Zhang L, Lin Z, et al. Prevalence and risk factors for bone loss in rheumatoid arthritis patients from South China: Modeled by three methods. BMC Musculoskelet. Disord. 2021;22(1):534. doi: https://doi.org/10.1186/s12891-021-04403-5</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Li X, Li L, Yang L, et al. No association between serum uric acid and lumbar spine bone mineral density in US adult males: A cross-sectional study. Sci. Rep. 2021;11(1):15588. doi: https://doi.org/10.1038/s41598-021-95207-z</mixed-citation><mixed-citation xml:lang="en">Li X, Li L, Yang L, et al. No association between serum uric acid and lumbar spine bone mineral density in US adult males: A cross-sectional study. Sci. Rep. 2021;11(1):15588. doi: https://doi.org/10.1038/s41598-021-95207-z</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Dalle Carbonare L, Giannini S. Bone microarchitecture as an important determinant of bone strength. J. Endocrinol. Invest. 2004;27(1):99–105. doi: https://doi.org/10.1007/BF03350919</mixed-citation><mixed-citation xml:lang="en">Dalle Carbonare L, Giannini S. Bone microarchitecture as an important determinant of bone strength. J. Endocrinol. Invest. 2004;27(1):99–105. doi: https://doi.org/10.1007/BF03350919</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Harvey NC, Glüer CC, Binkley N, et al. Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice. Bone. 2015;78:216–224. doi: https://doi.org/10.1016/j.bone.2015.05.016</mixed-citation><mixed-citation xml:lang="en">Harvey NC, Glüer CC, Binkley N, et al. Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice. Bone. 2015;78:216–224. doi: https://doi.org/10.1016/j.bone.2015.05.016</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Pothuaud L, Carceller P, Hans D. Correlations between grey-level variations in 2D projection images (TBS) and 3D microarchitecture: Applications in the study of human trabecular bone microarchitecture. Bone. 2008;42(4):775–787. doi: https://doi.org/10.1016/j.bone.2007.11.018</mixed-citation><mixed-citation xml:lang="en">Pothuaud L, Carceller P, Hans D. Correlations between grey-level variations in 2D projection images (TBS) and 3D microarchitecture: Applications in the study of human trabecular bone microarchitecture. Bone. 2008;42(4):775–787. doi: https://doi.org/10.1016/j.bone.2007.11.018</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Silva BC, Leslie WD, Resch H et al. Trabecular bone score: a noninvasive analytical method based upon the DXA image [published correction appears in J Bone Miner Res. 2017;32(11):2319] J. Bone Miner. Res. 2014;29(3):518–530. doi: https://doi.org/10.1002/jbmr.2176</mixed-citation><mixed-citation xml:lang="en">Silva BC, Leslie WD, Resch H et al. Trabecular bone score: a noninvasive analytical method based upon the DXA image [published correction appears in J Bone Miner Res. 2017;32(11):2319] J. Bone Miner. Res. 2014;29(3):518–530. doi: https://doi.org/10.1002/jbmr.2176</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Martineau P, Leslie WD, Johansson H, et al. Clinical utility of using lumbar spine trabecular bone score to adjust fracture probability: The Manitoba BMD cohort. J. Bone Miner. Res. 2017;32(7):1568–1574. doi: https://doi.org/10.1002/jbmr.3124</mixed-citation><mixed-citation xml:lang="en">Martineau P, Leslie WD, Johansson H, et al. Clinical utility of using lumbar spine trabecular bone score to adjust fracture probability: The Manitoba BMD cohort. J. Bone Miner. Res. 2017;32(7):1568–1574. doi: https://doi.org/10.1002/jbmr.3124</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Li Y, Tan J, Tian J, et al. Cross-sectional analysis of the correlation between serum uric acid and trabecular bone score: NHANES 2005-2008. Sci Rep. 2023;13(1):21546. doi: https://doi.org/10.1038/s41598-023-48739-5</mixed-citation><mixed-citation xml:lang="en">Li Y, Tan J, Tian J, et al. Cross-sectional analysis of the correlation between serum uric acid and trabecular bone score: NHANES 2005-2008. Sci Rep. 2023;13(1):21546. doi: https://doi.org/10.1038/s41598-023-48739-5</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Fardellone P, Salawati E, Le Monnier L et al. Bone Loss, Osteoporosis, and Fractures in Patients with Rheumatoid Arthritis: A Review. J Clin Med. 2020;9(10):3361. Published 2020 Oct 20. doi: https://doi.org/10.3390/jcm9103361</mixed-citation><mixed-citation xml:lang="en">Fardellone P, Salawati E, Le Monnier L et al. Bone Loss, Osteoporosis, and Fractures in Patients with Rheumatoid Arthritis: A Review. J Clin Med. 2020;9(10):3361. Published 2020 Oct 20. doi: https://doi.org/10.3390/jcm9103361</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao C, Xiao Q, Huang W, et al. Association between rheumatoid arthritis and hyperuricemia among adults: a cross-sectional study based on NHANES data. Clin Rheumatol. Published online March 6, 2025. doi: https://doi.org/10.1007/s10067-025-07386-z</mixed-citation><mixed-citation xml:lang="en">Zhao C, Xiao Q, Huang W, et al. Association between rheumatoid arthritis and hyperuricemia among adults: a cross-sectional study based on NHANES data. Clin Rheumatol. Published online March 6, 2025. doi: https://doi.org/10.1007/s10067-025-07386-z</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Lee HN, Kim A, Kim Y, Kim GT, Sohn DH, Lee SG. Higher serum uric acid levels are associated with reduced risk of hip osteoporosis in postmenopausal women with rheumatoid arthritis. Medicine (Baltimore). 2020;99(24):e20633. doi: https://doi.org/10.1097/MD.0000000000020633</mixed-citation><mixed-citation xml:lang="en">Lee HN, Kim A, Kim Y, Kim GT, Sohn DH, Lee SG. Higher serum uric acid levels are associated with reduced risk of hip osteoporosis in postmenopausal women with rheumatoid arthritis. Medicine (Baltimore). 2020;99(24):e20633. doi: https://doi.org/10.1097/MD.0000000000020633</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Veronese N, Carraro S, Bano G, et al. Hyperuricemia protects against low bone mineral density, osteoporosis and fractures: a systematic review and meta-analysis. Eur J Clin Invest. 2016;46(11):920-930. doi: https://doi.org/10.1111/eci.12677</mixed-citation><mixed-citation xml:lang="en">Veronese N, Carraro S, Bano G, et al. Hyperuricemia protects against low bone mineral density, osteoporosis and fractures: a systematic review and meta-analysis. Eur J Clin Invest. 2016;46(11):920-930. doi: https://doi.org/10.1111/eci.12677</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Pirro M, Mannarino MR, Bianconi V, et al. Uric acid and bone mineral density in postmenopausal osteoporotic women: the link lies within the fat. Osteoporos Int. 2017;28(3):973-981. doi: https://doi.org/10.1007/s00198-016-3792-3</mixed-citation><mixed-citation xml:lang="en">Pirro M, Mannarino MR, Bianconi V, et al. Uric acid and bone mineral density in postmenopausal osteoporotic women: the link lies within the fat. Osteoporos Int. 2017;28(3):973-981. doi: https://doi.org/10.1007/s00198-016-3792-3</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Tu J, Mo X, Zhang X, et al. BMI mediates the association of serum uric acid with bone heal th: a cross-sectional study of the National Health and Nutrition Examination Survey (NHANES). BMC Musculoskelet Disord. 2024;25(1):482. doi: https://doi.org/10.1186/s12891-024-07595-8</mixed-citation><mixed-citation xml:lang="en">Tu J, Mo X, Zhang X, et al. BMI mediates the association of serum uric acid with bone heal th: a cross-sectional study of the National Health and Nutrition Examination Survey (NHANES). BMC Musculoskelet Disord. 2024;25(1):482. doi: https://doi.org/10.1186/s12891-024-07595-8</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Торопцова Н.В., Добровольская О.В., Козырева М.В., и др. Есть ли связь между остеопорозом и мочевой кислотой? // Научно-практическая ревматология. — 2024. — Т.62. — №6. — С.622-626. doi: https://doi.org/10.47360/1995-4484-2024-622-626</mixed-citation><mixed-citation xml:lang="en">Toroptsova NV, Dobrovolskaya OV, Kozyreva MV, Demin NV. Is there an association between osteoporosis and uric acid? Rheumatology Science and Practice. 2024;62(6):622-626. (In Russ.). doi: https://doi.org/10.47360/1995-4484-2024-622-626</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Han W, Bai X, Wang N, et al. Association between lumbar bone mineral density and serum uric acid in postmenopausal women: a cross-sectional study of healthy Chinese population. Arch Osteoporos. 2017;12(1):50. doi: https://doi.org/10.1007/s11657-017-0345-0</mixed-citation><mixed-citation xml:lang="en">Han W, Bai X, Wang N, et al. Association between lumbar bone mineral density and serum uric acid in postmenopausal women: a cross-sectional study of healthy Chinese population. Arch Osteoporos. 2017;12(1):50. doi: https://doi.org/10.1007/s11657-017-0345-0</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
